Market Closed -
Nasdaq
04:00:00 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
25.99
USD
|
-1.52%
|
|
-5.42%
|
-53.56%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,333
|
15,237
|
16,640
|
4,171
|
6,615
|
3,111
|
-
|
-
|
Enterprise Value (EV)
1 |
6,939
|
14,574
|
16,052
|
3,741
|
6,226
|
2,710
|
2,619
|
2,461
|
P/E ratio
|
-95.3
x
|
-26.4
x
|
-281
x
|
-25
x
|
-25.7
x
|
-16.2
x
|
-26.3
x
|
-73.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
29.8
x
|
51
x
|
33.9
x
|
8.08
x
|
10.7
x
|
4.65
x
|
4.05
x
|
3.55
x
|
EV / Revenue
|
28.2
x
|
48.8
x
|
32.7
x
|
7.24
x
|
10.1
x
|
4.05
x
|
3.41
x
|
2.81
x
|
EV / EBITDA
|
-295
x
|
-28
x
|
-516
x
|
-26.2
x
|
-27.1
x
|
-17.3
x
|
-30.1
x
|
68.5
x
|
EV / FCF
|
-855
x
|
-57.2
x
|
-131
x
|
-22.6
x
|
-97.6
x
|
-14.5
x
|
-37.4
x
|
130
x
|
FCF Yield
|
-0.12%
|
-1.75%
|
-0.76%
|
-4.42%
|
-1.02%
|
-6.9%
|
-2.67%
|
0.77%
|
Price to Book
|
17.5
x
|
20.8
x
|
20.5
x
|
5.21
x
|
9
x
|
4.1
x
|
3.46
x
|
2.9
x
|
Nbr of stocks (in thousands)
|
96,170
|
107,607
|
111,707
|
114,464
|
118,209
|
119,708
|
-
|
-
|
Reference price
2 |
76.25
|
141.6
|
149.0
|
36.44
|
55.96
|
25.99
|
25.99
|
25.99
|
Announcement Date
|
2/18/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
245.9
|
298.8
|
490.5
|
516.4
|
618.7
|
669.8
|
768.5
|
876.6
|
EBITDA
1 |
-23.51
|
-520.1
|
-31.14
|
-142.6
|
-229.8
|
-156.6
|
-86.91
|
35.91
|
EBIT
1 |
-30.57
|
-86.59
|
-52.91
|
-167.9
|
-265.3
|
-198.8
|
-130
|
-46.01
|
Operating Margin
|
-12.43%
|
-28.98%
|
-10.79%
|
-32.52%
|
-42.88%
|
-29.68%
|
-16.91%
|
-5.25%
|
Earnings before Tax (EBT)
1 |
-31.03
|
-534.5
|
-53.72
|
-162
|
-248.8
|
-188
|
-119.3
|
-38.92
|
Net income
1 |
-31.25
|
-542.7
|
-58.22
|
-166
|
-255.1
|
-189.6
|
-119.3
|
-41.94
|
Net margin
|
-12.71%
|
-181.61%
|
-11.87%
|
-32.15%
|
-41.23%
|
-28.31%
|
-15.52%
|
-4.78%
|
EPS
2 |
-0.8000
|
-5.370
|
-0.5300
|
-1.460
|
-2.180
|
-1.603
|
-0.9884
|
-0.3549
|
Free Cash Flow
1 |
-8.115
|
-254.6
|
-122.7
|
-165.3
|
-63.8
|
-187
|
-70
|
19
|
FCF margin
|
-3.3%
|
-85.18%
|
-25.01%
|
-32%
|
-10.31%
|
-27.92%
|
-9.11%
|
2.17%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
52.91%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
143.5
|
114.5
|
114.6
|
131.1
|
156.2
|
134.3
|
146.8
|
153.6
|
184
|
141
|
151
|
174.4
|
202.6
|
168.8
|
179.5
|
EBITDA
1 |
-10.05
|
-35.54
|
-56.62
|
-33.84
|
-16.58
|
-45.51
|
-53.42
|
-85.42
|
-45.47
|
-52.3
|
-46.04
|
-32.51
|
-10.44
|
-40.19
|
-31.18
|
EBIT
1 |
-15.83
|
-41.74
|
-63.12
|
-40
|
-23.1
|
-51.99
|
-63.36
|
-94.8
|
-55.19
|
-61.5
|
-58.86
|
-48.4
|
-30.21
|
-45.38
|
-40.43
|
Operating Margin
|
-11.03%
|
-36.45%
|
-55.07%
|
-30.51%
|
-14.78%
|
-38.71%
|
-43.15%
|
-61.7%
|
-30%
|
-43.61%
|
-38.98%
|
-27.76%
|
-14.91%
|
-26.88%
|
-22.53%
|
Earnings before Tax (EBT)
1 |
-15.99
|
-41.69
|
-63.83
|
-40.04
|
-16.41
|
-49.65
|
-60.77
|
-91.74
|
-46.6
|
-57.8
|
-55.64
|
-43.86
|
-26.04
|
-44.71
|
-39.25
|
Net income
1 |
-18.45
|
-42.41
|
-64.46
|
-41.91
|
-17.22
|
-50.75
|
-62.41
|
-92.99
|
-48.95
|
-59.95
|
-56.61
|
-45.63
|
-26.83
|
-43.89
|
-38.27
|
Net margin
|
-12.85%
|
-37.04%
|
-56.24%
|
-31.98%
|
-11.02%
|
-37.79%
|
-42.51%
|
-60.52%
|
-26.61%
|
-42.52%
|
-37.49%
|
-26.17%
|
-13.25%
|
-26%
|
-21.33%
|
EPS
2 |
-0.1600
|
-0.3800
|
-0.5700
|
-0.3700
|
-0.1500
|
-0.4400
|
-0.5300
|
-0.7900
|
-0.4100
|
-0.5000
|
-0.4780
|
-0.3842
|
-0.2366
|
-0.3635
|
-0.3082
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/16/22
|
5/4/22
|
8/8/22
|
11/2/22
|
2/15/23
|
5/3/23
|
8/3/23
|
11/2/23
|
2/15/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
394
|
664
|
587
|
430
|
389
|
401
|
493
|
650
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-8.12
|
-255
|
-123
|
-165
|
-63.8
|
-187
|
-70
|
19
|
ROE (net income / shareholders' equity)
|
-31.2%
|
-93.6%
|
-7.48%
|
-20.5%
|
-33%
|
-24.1%
|
-10.5%
|
3.11%
|
ROA (Net income/ Total Assets)
|
-8.56%
|
-70.7%
|
-5.98%
|
-16.2%
|
-25.6%
|
-16.3%
|
-5.74%
|
1.7%
|
Assets
1 |
365.1
|
767.7
|
974.1
|
1,024
|
997.1
|
1,163
|
2,077
|
-2,472
|
Book Value Per Share
2 |
4.360
|
6.810
|
7.270
|
6.990
|
6.220
|
6.340
|
7.500
|
8.980
|
Cash Flow per Share
2 |
0.8900
|
-2.150
|
-0.1900
|
-0.3000
|
-0.1300
|
0.2100
|
0.5500
|
1.390
|
Capex
1 |
42.7
|
36.7
|
101
|
132
|
48.6
|
18.4
|
21.2
|
22.4
|
Capex / Sales
|
17.38%
|
12.27%
|
20.65%
|
25.5%
|
7.85%
|
2.74%
|
2.75%
|
2.56%
|
Announcement Date
|
2/18/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
25.99
USD Average target price
41.14
USD Spread / Average Target +58.30% Consensus |
1st Jan change
|
Capi.
|
---|
| -53.56% | 3.11B | | -1.29% | 12.64B | | -0.47% | 8.46B | | +5.68% | 5.66B | | +22.61% | 5.27B | | -2.03% | 4.49B | | +19.30% | 2.87B | | +33.07% | 2.31B | | -8.42% | 2.23B | | -3.55% | 1.89B |
Diagnostic & Testing Substances
|